The Germans Trias rare disease symposium promotes coordinated work between the laboratory and the clinic
The symposium has become a key event for sharing knowledge and experiences around these conditions.
At the IGTP TODAY
News
Germans Trias Hospital launches the first screening program in Catalonia to detect type 1 diabetes before the onset of symptoms
Early diagnosis can help prevent serious complications, reduce hospital admissions and minimise the impact of disease onset in children and adolescents
_1766478647.jpeg)
IGTP strengthens its presence at BIOSPAIN 2025 as a benchmark in innovation and knowledge transfer
The Institute has taken part in BIOSPAIN 2025, the leading biotechnology event in southern Europe, with the aim of strengthening its knowledge and technology transfer strategy, showcasing its innovation capabilities, and fostering new collaborations with companies, investors, and stakeholders across the biomedical ecosystem.
The Comparative Medicine and Bioimage Centre of Catalonia celebrates its fifth anniversary
CMCiB celebrated its first five years of activity with a symposium dedicated to pioneering biomedical research at CosmoCaixa.
Progress in developing specific immunotherapies for type 1 diabetes
Researchers from IGTP and Ahead Therapeutics have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 diabetes for years. A study recently published in the Journal of Autoimmunity examines the response of macrophages to this immunotherapy, serving as a preliminary step before clinical trials.
Can Ruti celebrates a Rare Disease Day symposium highlighting the importance of research to help patients
On Thursday 29 February, the Germans Trias Hospital hosted the 'International Rare Disease Day Symposium'. Health professionals and researchers from the Hospital and IGTP discussed their work in advancing the field of rare diseases. Representatives from patient associations of these diseases also participated.
A year in review: 2023 highlights at IGTP
In 2023, the IGTP has continued to make significant strides in its mission. Here, we review the year's top news stories, reflecting the persistent drive and collaborative spirit that underpin this institution.
- Research
Type 1 diabetes research sheds light on biomarkers in partial remission phase
Researchers from the IGTP have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes, in collaboration with experts in β-cell biology and regeneration from the Diabetes Research Institute in Miami. The study has been published in the journal Trends in Endocrinology and Metabolism.
The podcast 'Un bri de ciència' explores type 1 diabetes in its second episode
The new episode of the podcast 'Un bri de ciència' is presented under the title "La diabetis tipus 1: quan la defensa t'ataca" (Type 1 diabetes: when your defences attack you). Researcher Marta Vives Pi explains the problems of autoimmune diseases, with an emphasis on type 1 diabetes.
- Research
Studying partial remission of type 1 diabetes in children: New biomarkers and the immunoregulatory role of microRNA
A study led by researchers from IGTP's Immunology of Diabetes group has identified new microRNA as biomarkers for the partial remission phase, also known as "honeymoon phase", of type 1 diabetes, and has linked the miR-30d-5p microRNA to immunoregulatory processes that may take place during this phase.
